NYSEARCA:SBIO ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free SBIO Stock Alerts $31.86 -0.38 (-1.18%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$31.80▼$32.3550-Day Range$31.59▼$38.6952-Week Range$23.21▼$38.80Volume22,859 shsAverage Volume12,425 shsMarket Capitalization$101.95 millionAssets Under Management$102.17 millionDividend Yield0.21%Net Expense Ratio0.50% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get ALPS Medical Breakthroughs ETF alerts: Email Address About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.Read More SBIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBIO ETF News HeadlinesApril 17, 2024 | finance.yahoo.comALPS Medical Breakthroughs ETF (SBIO)February 22, 2024 | benzinga.comALPS ETF Trust ALPS Intermediate Municipal Bond ETF (ARCA:MNBD) Dividends: History, Yield and DatesApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 11, 2024 | msn.comI checked into a £40,000-a-week rehab in the Swiss AlpsJanuary 19, 2024 | seekingalpha.comHow ETF Investors Can Take Advantage Of Deal ActivityDecember 30, 2023 | finance.yahoo.comBiotech ETF SBIO’s Momentum Strong to End 2023December 22, 2023 | msn.comALPS Medical Breakthroughs ETF declares annual distribution of $0.0711December 10, 2023 | finance.yahoo.comPlay US Gene Treatment Approval in SBIOApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.September 12, 2023 | finance.yahoo.comSBIO - ALPS Medical Breakthroughs ETFSee More Headlines Receive SBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerALPS Fund NameALPS Medical Breakthroughs ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SBIO Inception Date12/31/2014 Fund ManagerRyan Mischker, Andrew Hicks WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS-Network Medical Breakthroughs Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings97 Fund Statistics Assets Under Management$102.17 million Average Daily Volume$10,316.10 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorALPS Fund Services, Inc. AdvisorALPS Advisors, Inc. CustodianState Street Bank and Trust Company DistributorALPS Portfolio Solutions Distributor, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerGTS Options OptionableOptionable Options Volume2 Put Options2 Call Options12 Short Interest12,300 shs Miscellaneous Outstanding Shares3,200,000Beta1.03 Creation Unit50,000 Creation Fee$500.00 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… ALPS Medical Breakthroughs ETF ExpensesTypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.56%0.54%0.50%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.50%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.54%-0.68%-0.57%Net Expense0.50%0.60%0.60%0.58%0.58% ALPS Medical Breakthroughs ETF (SBIO) Holdings & ExposureTop 10 SBIO HoldingsCerevel Therapeutics(NASDAQ:CERE)Holding Weight: 4.84%Viking Therapeutics(NASDAQ:VKTX)Holding Weight: 4.72%Vaxcyte(NASDAQ:PCVX)Holding Weight: 4.45%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 3.91%Alpine Immune Sciences(NASDAQ:ALPN)Holding Weight: 2.68%Alkermes(NASDAQ:ALKS)Holding Weight: 2.65%Crinetics Pharmaceuticals(NASDAQ:CRNX)Holding Weight: 2.37%Axsome Therapeutics(NASDAQ:AXSM)Holding Weight: 2.15%SpringWorks Therapeutics(NASDAQ:SWTX)Holding Weight: 2.06%Xenon Pharmaceuticals(NASDAQ:XENE)Holding Weight: 2.06%SBIO Sector ExposureSBIO Industry ExposureFull Holdings Details Similar ETFsSimplify Propel Opportunities ETFNYSEARCA:SURIProShares Ultra Health CareNYSEARCA:RXLSimplify Health Care ETFNYSEARCA:PINKDirexion Daily S&P Biotech Bear 3X SharesNYSEARCA:LABDProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipCentral Valley Advisors LLCBought 5,606 shares on 4/12/2024Ownership: 0.175%Virtu Financial LLCBought 15,725 shares on 2/26/2024Ownership: 0.453%Strategic Financial Services Inc Sold 44,548 shares on 2/8/2024Ownership: 0.573%NTV Asset Management LLCSold 12,526 shares on 2/6/2024Ownership: 0.941%Phoenix Wealth AdvisorsBought 1,130 shares on 1/30/2024Ownership: 0.315%View All Institutional Transactions SBIO ETF - Frequently Asked Questions How have SBIO shares performed in 2024? ALPS Medical Breakthroughs ETF's stock was trading at $32.94 at the beginning of 2024. Since then, SBIO shares have decreased by 3.3% and is now trading at $31.8603. View the best growth stocks for 2024 here. What does SBIO invest in? ALPS Medical Breakthroughs ETF is a equity fund issued by ALPS. SBIO focuses on health care investments and follows the S-Network Medical Breakthroughs Index. The fund's investments total to approximately $102.17 million assets under management. What stocks does ALPS Medical Breakthroughs ETF hold? SBIO invests in 97 holdings. Some of the stocks in their portfolio include Cerevel Therapeutics (CERE), Viking Therapeutics (VKTX), Vaxcyte (PCVX), Revolution Medicines (RVMD), Alpine Immune Sciences (ALPN), Alkermes (ALKS), Crinetics Pharmaceuticals (CRNX), Axsome Therapeutics (AXSM), SpringWorks Therapeutics (SWTX) and Xenon Pharmaceuticals (XENE). What is the management fee for ALPS Medical Breakthroughs ETF? ALPS Medical Breakthroughs ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for SBIO is 0.50%. What other stocks do shareholders of ALPS Medical Breakthroughs ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX). Who are ALPS Medical Breakthroughs ETF's major shareholders? ALPS Medical Breakthroughs ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Central Valley Advisors LLC (0.18%). How do I buy shares of ALPS Medical Breakthroughs ETF? Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:SBIO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
